Skip to main content

Evonik completes future scenario project

2nd July 2019

Submitted by:

Andrew Warmington

Evonik has carried out the ‘Future(s) of the Specialty Chemicals Industry’ project, which it claims to be the largest study ever conducted using scenario planning in the sector. It aims to use the results “to initiate innovations early and in a targeted way” and to develop and update its long-term strategies.

The company’s Corporate Foresight team carried out over 100 interviews with internal and external experts in chemistry, politics and economics, looked at futurology studies and conducted over 15 workshops, seeking to answer one key question: what major forces could have a long-term impact on speciality chemicals companies? Five, often conflicting, scenarios were outlined:

1. Digital Champions, where major internet companies draw most from the value chain of traditional industries

2. Sustainability Paradigm, in which sustainability becomes the guiding economic principle

3. Chinese Dream, with China as technological, economic and political world power

4. Turbulent Times, where nationalism and populism lead to prolonged deglobalisation

5. Deceptive Calm, in which efforts to prop up the status quo piles up problems until it might collapse

Describing these as “very well-researched science fiction”, Harald Schwager, the deputy chairman and board member responsible for innovation, said: “The results of the scenario project now put a fascinating, strategic tool at our disposal. One that will help us model today’s ideas for innovations on the potential developments of tomorrow.”

The results are already being used in innovation processes and strategies, the company said. There will be workshops to analyse the impact of the scenarios on issues like the innovative environment, business models, customer expectations, working conditions and material flows. Business areas and regional organisations will also use them to test the robustness of existing strategies and develop new ones.

Evonik is placing an emphasis on six innovation growth fields, for which it aims to generate €1 billion more in sales by 2025: sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions and additive Manufacturing. It achieved €250 million in these field in 2018 fields.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington